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Conventional Photodynamic Therapy (PDT) is a well-established treatment for cutaneous cancers 1 
such as basal cell carcinoma (BCC), squamous cell carcinoma-in-situ (SCCis) and actinic keratosis 2 
(AK).1 A high intensity light source is utilised with the main complaint from patients being burning pain 3 
from the outset which often continues well after procedural completion.2 Pain is a particularly 4 
unpleasant experience and is widely associated with treatment abandonment and thus a significant 5 
therapy-limiting factor.3,4 6 
We assessed local anaesthetic (LA) versus no analgesia or cooling water spray/aerosol (NA/CWS) for 7 
pain management in conventional PDT (MAL-PDT). A single-site, retrospective review was performed 8 
over a three-year period for patients who received PDT to treat a solitary lesion. The Numeric Pain 9 
Rating Scale from zero (no pain) to 10 (worst pain ever experienced) was employed; data from first 10 
and second sessions of a PDT cycle were analysed with Minitab v18 (Minitab Inc., USA). 11 
Included were male and female patients over 18-years-old who received PDT on at least one 12 
occasion. If a patient underwent multiple sessions but on different body sites they were recorded 13 
separately. Only treatments that involved NA/CWS or subcutaneous LA were included; combination 14 
regimens were excluded. Patients were excluded if treatment was abandoned during the procedure 15 
and if any patient requiring two sessions changed analgesic regimen between them, they had their 16 
second session excluded. Finally, light source heights other than 5cm/8cm were excluded. 17 
Fifty-nine patients with 95 treatments for AK, Bowen’s disease or nodular or superficial BCC were 18 
eligible. The total number of treatments is greater for session 1 (n=56) than session 2 (n=39) due to 19 
some patients requiring only one session, and others switching analgesic regimens. As shown in 20 
Fig.1, NA/CWS produced a median (range) pain score of 5 (0 to 10) for the first session and 3 (0 to 9) 21 
for the second session. With LA the median was zero for both sessions (0 to 3; session 1 and 0 to 4; 22 
session 2). The pain scores of each group were similar between sessions with a median difference of 23 
0 (-2 to 0.5; 95%CI) for NA/CWS and 0 (0 to 0.5; 95%CI) with LA (Wilcoxon paired test for both). The 24 
overall difference in pain scores between groups was significant (p<0.001, Mann-Whitney test) in 25 
session 1 and similarly for session 2 (p<0.001, Mann-Whitney test). 26 
<FIGURE01> 27 
Limitations of this study include absence of randomisation, small cohort number and the potential for 28 














in this study. This pilot study suggests subcutaneous LA to be an effective method of pain relief in 30 
conventional PDT for solitary lesions. Its use has considerable implications in patient experience and 31 
tolerance and may help reduce the rate of therapy abandonment. Our results suggest patients be 32 
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Abbreviation & Acronym list 45 
Photodynamic Therapy (PDT)  46 
Basal cell carcinoma (BCC) 47 
Squamous cell carcinoma-in-situ (SCCis)  48 
Actinic keratosis (AK)  49 















Figure Legend 52 
Figure 1: Difference in median and interquartile range between the analgesic regimens in session one 53 
and two. Each boxplot shows the median (line with filled circle) and the interquartile range (box and 54 
whiskers) excluding outliers (> 1.5 the interquartile range) shown with an asterisk (*). 55 
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